Bioethical evaluation of methylphenidate and atomoxetine for pediatric ADHD and cognitive enhancement

CONCLUSION: The study advocates for a cautious approach to cognitive enhancement, emphasizing the preservation of the individual’s well-being over performance gains. In the context of ADHD treatment, it calls for an ethical examination of the long-term effects of Methylphenidate and Atomoxetine use in children and adolescents, recommending a preference for behavioral treatments when possible. Pediatric ADHD: There is a notable scarcity of data regarding the prevalence of therapeutic benefits…

via https://pubmed.ncbi.nlm.nih.gov/40102913/?utm_source=Other&utm_medium=rss&utm_campaign=None&utm_content=1L37KAMf2b_g4WEK3LmdFuKZu9pO3cN7u4ZmO9PPCPeBLMIw1q&fc=None&ff=20250331010908&v=2.18.0.post9+e462414